Protection Against Marburg Virus Using a Recombinant VSV-Vaccine Depends on T and B Cell Activation

Marburg virus (MARV) is the causative agent of hemorrhagic fever outbreaks with high case fatality rates. Closely related to Ebola virus, MARV is a filamentous virus with a negative-sense, single-stranded RNA genome. Although extensive studies on filovirus countermeasures have been conducted, there...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Front Immunol
Päätekijät: Marzi, Andrea, Menicucci, Andrea R., Engelmann, Flora, Callison, Julie, Horne, Eva J., Feldmann, Friederike, Jankeel, Allen, Feldmann, Heinz, Messaoudi, Ilhem
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2019
Aiheet:
Immunology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6350103/
https://ncbi.nlm.nih.gov/pubmed/30723475
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.03071
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia